Ken Griffin's position in Zevra Therapeutics is currently worth $1.95 Million. That's 0.00% of their equity portfolio (2248th largest holding). The first Zevra Therapeutics trade was made in Q1 2021. Since then Ken Griffin bought shares four more times and sold shares on five occasions. The stake costed the investor $1.7 Million, netting the investor a gain of 14% so far.